Abstract
Synthetic leukotrienes C4 and D4 (LTC and LTD) were found to possess potent coronary vasoconstrictor and cardiac depressant actions on isolated guinea-pig hearts. We therefore went further to investigate the possibility that endogenously released slow-reacting substance of anaphylaxis (SRS-A) might be responsible for the coronary vasoconstriction and negative inotropism in guinea-pig cardiac anaphylaxis. Results using time-course analysis as well as the specific SRS antagonist FPL 55712 have shown that SRS-A released during cardiac anaphylaxis was unlikely to be responsible for the early and most dramatic phase of coronary vasoconstriction that usually occurred at the 2nd min after antigen challenge, but could possibly be responsible for the latter and more prolonged phase occurring between the 6th and 14th min. This is because SRS-A release was found to peak at the 4th min after antigen challenge, 2 min after vasoconstriction had already peaked. Moreover, this early component of coronary vasoconstriction could not be blocked by FPL 55712, whereas the latter component was significantly reduced by the antagonist.
The negative inotropism following cardiac anaphylaxis was also found to be significantly reduced by FPL 55712, thus suggesting SRS-A involvement. However, our experiments did not show whether the two actions were direct effects of SRS-A or whether contractility failure was a consequence of coronary vasoconstriction.
Similar content being viewed by others
References
G.A. Feigen andD.J. Prager,Experimental cardiac anaphylaxis: Physiologic, pharmacologic and biochemical aspects of immune reactions in the isolated heart, Am. J. Cardiol.24, 474–491 (1969).
R. Levi,Effects of exogenous and immunologically released histamine on the isolated heart: A quantitative comparison, J. Pharmac. exp. Ther.182, 227–238 (1972).
R. Levi, J.H. Zavecz andZ. Ovary,IgE-mediated cardiac hypersensitivity reactions, Int. Archs Allergy appl. Immun.57, 529–534 (1978).
H. Anhut, W. Bernauer andB.A. Peskar,Radio-immunological determination of thromboxane release in cardiac anaphylaxis, Eur. J. Pharmac.44, 85–88 (1977).
A. Giotti, A. Guidotti, P.F. Mannaioni andL. Zilletti,The influences of adrenotropic drugs and noradrenaline on the histamine release in cardiac anaphylaxis in vitro, J. Physiol., Lond.184, 924–941 (1966).
W.E. Brocklehurst,The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock, J. Physiol. Lond.151, 416–435 (1960).
R. Liebig, W. Bernauer andB.A. Peskar,Prostaglandin, slow reacting substance and histamine release from anaphylactic guinea-pig hearts and its pharmacological modification, Naunyn-Schmiedebergs Arch. Pharmak. exp. Path.289, 65–76 (1975).
G. Allan, J.H. Zavecz andR. Levi,Release of prostaglandins and SRS-A during cardiac anaphylaxis (Abs.), Bull. N.Y. Acad. Med.53, 304 (1977).
G. Allan andR. Levi,Thromoxane and prostacyclin release during cardiac immediate hypersensitivity reactions in vitro, J. Pharmac. exp. Ther.217, 157–161 (1981).
R.A. Lewis, K.F. Austen, J.M. Drazen, D.A. Clark, A. Marfat andE.J. Corey,Slow reacting substances of anaphylaxis: Identification of leukotrienes C-1 and D from human and rat sources, Proc. natn. Acad. Sci. USA77, 3710–3714 (1980).
Z. Terashita, H. Fukui, M. Hirata, S. Terao, S. Ohkawa, K. Nishikawa andS. Kikuchi,Coronary vasoconstriction and PGI 2 release by leukotrienes in isolated guinea-pig hearts, Eur. J. Pharmac.73, 357–361 (1981).
L.G. Letts andP.J. Piper,The actions of leukotrienes C 4 and D 4 on guinea-pig isolated hearts, Br. J. Pharmac. Chemother.76, 169–176 (1982).
J.A. Burke, R. Levi, Z. Guo andE.J. Corey,Leukotrienes C 4,D 4 and E 4:Effects on human and guinea-pig cardiac preparations in vitro, J. Pharmac. exp. Ther.221, 235–241 (1982).
P.A. Shore, A. Burkhalter andV.H. Cohn,A method for the fluorometric assay of histamine in tissues, J. Pharmac. exp. Ther.127, 182–186 (1959).
J.P. Trzeciakowski andR. Levi Cardiac histamine: a mediator in search of a function, Trends in Pharmacological Sciences2, 14–17 (1981).
H.J.L. Marriott, Coronary insufficiency and related matters. InPractical Electrocardiography, 5th ed., pp. 254–267 (Ed.H.J.L. Marriott) Baltimore 1974.
H. Anhut, W. Bernauer andB.A. Peskar,Pharmacological modification of thromboxane and prostaglandin release in cardiac anaphylaxis, Prostaglandins15, 889–900 (1978).
G. Allan andR. Levi,The cardiac effects of prostaglandins and their modification by the prostaglandin antagonist N-0164, J. Pharmac. exp. Ther.214, 45–49 (1980).
E.F. Ellis, O. Oelz, L.J. Roberts, N.A. Payne, B.J. Sweetman, A.S. Nies andJ.A. Oates,Coronary arterial smooth muscle contraction by a substance release from platelets: Evidence that it is thromboxane A 2, Science193, 1135–1137 (1976).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ezeamuzie, I.C., Assem, E.S.K. Effects of leukotrienes C4 and D4 on guinea-pig heart and the participation of SRS-A in the manifestations of guinea-pig cardiac anaphylaxis. Agents and Actions 13, 182–187 (1983). https://doi.org/10.1007/BF01967327
Issue Date:
DOI: https://doi.org/10.1007/BF01967327